Recent epidemiological, biological, and behavioral evidence suggests that sleep disorders may contribute to the development of diabetes; conversely, diabetes itself may contribute to sleep disorders. Sleep appears to moderate the neurohormones that regulate blood glucose. Sleep deprivation and sleep disorders contribute to pathophysiological changes associated with the development of type 2 diabetes. In people who already have diabetes, sleep deprivation contributes to elevations of hemoglobin A1c. Symptoms that occur as a result of diabetes, such as nocturia and neuropathic pain, may in turn contribute to sleep disturbance and exacerbate sleep deprivation. The purposes of this article are to examine the scientific basis for the associations between diabetes and sleep, identify gaps in the understanding of the empirical underpinnings of these relationships, and propose directions for future research.
Al-Delaimy, W.K., Manson, J.E., Willett, W.C., Stampfer, M.J., & Hu, F.B. (2002). Snoring as a risk factor for Type II diabetes mellitus: A prospective study. American Journal of Epidemiology , 155, 387-393.
2.
American Diabetes Association. (2003). Economic costs of diabetes in the U.S. in 2002. Diabetes Care , 26, 917-932.
3.
Asplund, R. (2002). Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. British Journal of Urology International, 90, 533-536.
4.
Asplund, R. (2004). Nocturia, nocturnal polyuria, and sleep quality in the elderly. Journal of Psychosomatic Research, 56, 517-525.
5.
Ayas, N.T., White, D.P., Al-Delaimy, W.K., Manson, J.E., Stampfer, M.J., Speizer, F.E., et al. (2003). A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care, 26, 380-384.
6.
Bassetti, C. (2005). Sleep and stroke. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 811-838). Philadelphia: Elsevier Saunders.
7.
Benbow, S., Wallymahmed, M., & MacFarlane, I. (1998). Diabetic peripheral neuropathy and quality of life. QJM, 91, 733-737.
8.
Bixler, E.O., Vgontzas, A.N., Lin, H., Ten Have, T., Rein, J., Vela-Bueno, A., et al. (2001). Prevalence of sleep-disordered breathing in women: Effects of gender . American Journal of Respiratory and Critical Care Medicine , 163, 608-613.
9.
Bixler, E.O., Vgontzas, A. N., Ten Have, T., Tyson, K., & Kales, A. (1998). Effects of age on sleep apnea in men. American Journal of Respiratory and Critical Care Medicine, 157, 144-148.
10.
Bjorkelund, C., Bondyr-Carlsson, D., Lapidus, L., Lissner, L., Mansson, J., Ingmar, S., et al. (2005). Sleep disturbances in midlife unrelated to 32-year diabetes incidence: The prospective population study of the women of Gothenburg. Diabetes Care, 28, 2739-2744.
11.
Bonnet, M.H. (2005). Acute sleep deprivation. In M. H. Kryger, T. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 51-66). Philadelphia: Elsevier Saunders.
12.
Borbely, A.A., & Achermann, P. (1999). Sleep homeostasis and models of sleep regulation . Journal of Biological Rhythms, 14, 557-568.
13.
Buckley, T.M., & Schatzberg, A.F. (2005). On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. Journal ofClinical Endocrinology and Metabolism, 90, 3106-3114.
14.
Buysse, D.J. (2004). Insomnia, depression, and aging: Assessing sleep and mood interactions in older adults. Geriatrics, 59(2), 47-51.
15.
Carskadon, M.A., & Rechtschaffen, A. (2005). Monitoring and staging human sleep. In M. H. Kryger, T.H. Roth, & W. C. Dement (Eds.), Principals and practice of sleep medicine (4th ed., pp. 1359-1377). Philadelphia : Elsevier Saunders.
16.
Carlson, J.T., Hedner, J., Elam, M., Ejnell, H., Sellgren, J., & Wallin, B.G. (1993). Augumented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest, 103, 1763-1768.
17.
Centers for Disease Control and Prevention. ( 2004). National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2003 (Rev. ed.). Atlanta, GA: U.S. Department of Health and Human Services . Retrieved August 3, 2005, from http://www.cdc.gov/diabetes/pubs/factsheet.htm#citation
18.
Centers for Disease Control and Prevention. (n.d.). National diabetes fact sheet: National estimates on diabetes. Retrieved August 3, 2005, from http://www.cdc.gov/diabetes/pubs/estimates.htm
19.
Charloux, A., Gronfier, C., Lonsdorfer-Wolf, E., Piquard, F., & Brandenberger, G. (1999). Aldosterone release during the sleep-wake cycle in humans. American Journal of Physiology, Endocrinology, and Metabolism, 276, E43-E49.
20.
Chasens, E.R., & Umlauf, M.G. (2003). Nocturia: A problem that disrupts sleep and predicts OSA. Geriatric Nursing, 24, 76-105.
21.
Chasens, E.R., Umlauf, M.G., Pillion, D.J., & Wells, J.A. (2002). Nocturnal polyuria in type 2 diabetes: A symptom of obstructive sleep apnea. The Diabetes Educator, 28, 424-434.
22.
Coughlin, S.R., Mawdsley, L., Mugarza, J.A., Calverley, P.M.A., & Wilding, J.P.H. (2004). Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome . European Heart Journal, 25, 735-741.
23.
Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P., et al. (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
24.
Elmasry, A., Lindberg, E., Berne, C., Janson, C., & Gislason, T. (2001). Sleep-disordered breathing and glucose metabolism in hypertensive men: A population based study. Journal of Internal Medicine, 249, 153-161.
25.
Everson-Rose, S.A., Meyer, P.M., Powell, L.H., Pandey, D., Torrens, J.I., Kravitz, H.M., et al. (2004). Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care, 27, 2856-2862.
26.
Fernandez-Real, J.-M., Vayreda, M., Richart, C., Gutierrez, C., Broch, M., Vendrell, J., et al. (2001). Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Journal of Clinical Endocrinology and Metabolism, 86, 1154-1159.
27.
Fitzgerald, M.P., Mulligan, M., & Parthasarathy, S. (2006). Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. American Journal of Obstetrics and Gynecology , 194, 1399-1403.
28.
Foster, G., Millman, R., Sanders, M., Zammit, G., & Kuna, S. (n.d.). Sleep apnea in Look AHEAD (Action for Health in Diabetes). Retrieved February 21, 2007, from http://clinicaltrials.gov/ct/show/NCT00194259;jsessionid=FE1C2D5B379FFC395ED8063890C1958E?order=7
29.
Galer, B.S., Gianas, A., & Jensen, M.P. (2000). Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diabetes Research andClinical Practice, 47, 123-128.
30.
Gislason, T., & Almqvist, M. (1987). Somatic diseases and sleep complaints: An epidemiological study of 3,201 Swedish men. Acta Medica Scandinavia, 221, 475-481.
31.
Gonzalez-Ortiz, M., Martinez-Abundis, E., Balcazar-Monoz, B.R., & Pascoe-Gonzalez. (2000). Effect of sleep deprivation on insulin sensitivity and cortisol concentration in healthy subjects. DiabetesNutrition and Metabolism, 13, 80-83.
32.
Gottlieb, D.J., Punjabi, N.M., Newman, A., Resnick, H.E., Redline, S., Baldwin, C.M., et al. (2005). Association of sleep time with diabetes mellitus and impaired glucose tolerance. Archives ofInternal Medicine, 165, 863-868.
33.
Guilleminault, C., & Bassiri, A. (2005). Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and upper airway resistance syndrome. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 1043-1065). Philadelphia: Elsevier Saunders.
34.
Hirshkowitz, M., & Kryger, M.H. (2005). Monitoring techniques for evaluating suspected sleep-disordered breathing. In M. H Kryger , T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 1378-1402). Philadelphia: Elsevier Saunders.
35.
Hossain, J.L., & Shapiro, C.M. (2002). The prevalence, cost implications, and management of sleep disorders: An overview. Sleep and Breathing, 6, 85-102.
36.
Hyyppa, M.T., & Kronholm, E. (1989). Quality of sleep and chronic illnesses. Journal ofClinical Epidemiology, 42, 633-638.
37.
Ip, M.S.M., Lam, B., Ng, M.M.T., Lam, W.K., Tsang, K.W.T., & Lam, K.S.L. (2002). Obstructive sleep apnea is independently associated with insulin resistance. American Journal of Respiratory and Critical Care Medicine, 165, 670-676.
38.
Irwin, M.R., Wang, M., Campomayor, C.O., Collado-Hildalgo, A., & Cole, A. (2006). Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Archives ofInternal Medicine, 166, 1756-1762.
39.
Kawakami, N., Takatsuka, N., & Shimizu, H. (2004). Sleep disturbance and the onset of type 2 diabetes . Diabetes Care, 27, 282-283.
40.
Knutson, K.L., Ryden, A.M., Mander, B.A., & Van Cauter, E. (2006). Role of sleep duration and quality in risk and severity of type 2 diabetes mellitus. Archives ofInternal Medicine, 166, 1768-1774.
41.
Lamond, N., Tiggemann, M., & Dawson, D. (2000). Factors predicting sleep disruption in type 2 diabetes. Sleep, 23, 415-416.
42.
Lofaso, F., Lorino, A.M., Fodil, R., D'Ortho, M.P., Isabey, D., Lorino, H., et al. (1998). Heavy snoring with upper airway resistance syndrome may induce intrinsic positive end-expiratory pressure. Journal of Applied Physiology, 85, 860-866.
43.
Mallon, L., Broman, J.-E., & Hetta, J. (2005). High incidence of diabetes in men with sleep complaints . Diabetes Care, 28, 2762-2767.
44.
Meisinger, C., Heir, M., & Loewel, H. (2005). Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia: Clinical and Experimental Diabetes andMetabolism, 48, 235-241.
45.
Mistlberger, R.E., & Rusak, B. (2005). Circadian rhythms in mammals: Formal properties and environmental influences. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (pp. 321-350). Philadelphia: ElsevierSaunders.
46.
National Commission on Sleep Disorders Research. (1992). Overview of the findings of the National Commission on Sleep Disorders Research (1992). Retrieved September 18, 2005, from http://www.stanford.edu/~dement/overview-ncsdr.html
47.
National Diabetes Information Clearinghouse. ( 2005). National diabetes statistics. NIH Publication No. 06-3892. Retrieved January 15, 2007, from http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#7
48.
Nilsson, P.M., Roost, M., Engstrom, G., Hedblad, B., & Bergland, G. (2004). Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care, 27, 2464-2469.
49.
Perlis, M.L., Smith, M.T., & Pigeon, W.R. (2005). Etiology and pathophysiology of insomnia. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 714-725). Philadelphia: Elsevier Saunders.
50.
Phillips, B., Kato, M., Krzysztof, N., Choe, I., & Somers, V.K. (2000). Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. American Journal of PhysiologyHeart and Circulatory Physiology, 279, H234-H237.
51.
Phillips, B., & Kryger, M.H. (2005). Management of obstructive sleep apnea syndrome: Overview. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (pp. 321-350). Philadelphia: ElsevierSaunders .
52.
Pickup, J.C., Mattock, M.B., Chusney, G.D., & Burt, D. (1997). NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 40, 1286-1292.
53.
Pinto, L.R., Seabra, M., & Tufik, S. (2004). Different criteria of sleep latency and the effect of melatonin on sleep consolidation. Sleep, 27, 1089-1092.
54.
Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., & Ridker, P.M. (2001). C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA, 286, 327-334.
55.
Punjabi, N.M., Shahar, E., Redline, S., Gottlieb, D.J., Givelber, R., & Resnick, H.E. (2004). Sleep-disordered breathing, glucose intolerance, and insulin resistance. American Journal of Epidemiology, 160, 521-530.
56.
Punjabi, N.M., Sorkin, J.D., Katzel, L.I., Goldberg, A.P., Schwartz, A.R., & Smith, P.L. (2002). Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. American Journal of Respiratory and Critical Care Medicine, 165, 677-682.
57.
Rechtschaffen, A., & Kales, A. (1968). A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, University of California.
58.
Reichmuth, K.J., Austin, D., Skatrud, J.B., & Young, T. (2005). Association of sleep apnea and type 2 diabetes: A population based study [Electronic version]. American Journal of Respiratory and Critical Care Medicine, 172,1590-1595.
59.
Rodenbeck, A., & Hajak, G. (2001). Neuroendocrine dysregulation in primary insomnia . Revue Neurologique, 157(11Pt2), 5S57-55S61.
60.
Ryden, A.M., Knutson, K.L., Mander, B.A., & Van Cauter, E. (2002). Sleep in type 2 diabetes: A survey study. Sleep, 25(Abstract supplement), A105-A106.
61.
Ruan, H., Hacohen, N., Golub, T.R., Van Parijs, L., & Lodish, H.F. (2002). Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory. Diabetes, 51, 1319-1336.
62.
Scheen, A.J., & Van Cauter, E. (1998). The roles of time of day and sleep quality in modulating glucose regulation: Clinical implications . Hormone Research, 49, 191-201.
63.
Spiegel, K., Leproult, R., & Van Cauter, E. (1999). Impact of sleep debt on metabolic and endocrine function. Lancet, 354, 1435-1439.
64.
Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine , 141, 846-850.
65.
Sridhar, G.R., & Madhu, K. (1994). Prevalence of sleep disturbances in diabetes mellitus. Diabetes Research andClinical Practice, 23, 183-186.
66.
Steiger, A. (2003). Sleep and endocrinology. Journal of Internal Medicine, 254, 13-22.
67.
Sulit, L., Storfer-Isser, A., Kirchner, L., & Redline, S. (2006). Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep, 29, 777-783. Thorpy, M.J. (2002). SleepMultiMedia: The computerized textbook of sleep medicine v.5.0 [CD-ROM]. Scarsdale, NY: Sleep Multimedia.
68.
Trans-NIH Sleep Research Coordinating Committee. (2003). 2003 National sleep disorders research plan (NIH Publication No. 03-5209). Bethesda, MD: National Institute of Health, National Heart, Lung, and Blood Institute, National Center on Sleep Disorder Research.
69.
Van Cauter, E. (2005). Endocrine physiology. In M. H. Kryger, T. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 266-282). Philadelphia: Elsevier Saunders.
70.
Van Cauter, E., Polansky, K.S., & Scheen, A.J. (1997). Roles of circadian rhythmicity and sleep in human glucose regulation. Endocrine Reviews, 18, 716-738.
71.
Vaughn, B.V., & D'Cruz, O.F. (2005). Cardinal manifestations of sleep disorders. In M. H. Kryger, T. H. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (4th ed., pp. 594- 601). Philadelphia : ElsevierSaunders.
72.
Vgontzas, A.N., Bixler, E.O., & Chrousos, G.P. (2003). Metabolic disturbances in obesity versus sleep apnea: The importance of visceral obesity and insulin resistance. Journal of Internal Medicine, 254, 32-44.
73.
Vgontzas, A.N., Bixler, E.O., Lin, H.-M., Prolo, P., Mastorakos, G., Vela-Bueno, A., et al. (2001). Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: Clinical implications. Journal ofClinical Endocrinology and Metabolism, 86, 3787-3794.
74.
Vgontzas, A.N., Legro, R.S., Bixler, E.O., Grayev, A., Kales, A., & Chrousos, G.P. (2001). Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: Role of insulin resistance. Journal ofClinical Endocrinology and Metabolism, 86, 517-520.
75.
Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Hopper, K., Lotsikas, A., Lin, H.-M., et al. (2000). Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. Journal ofClinical Endocrinology and Metabolism, 85, 1151-1158.
76.
Vgontzas, A.N., Tsigos, C., Bixler, E.O., Stratakis, C.A., Zachman, K., Kales, A., et al. (1998). Chronic insomnia and activity of the stress system: A preliminary study. Journal of Psychosomatic Research , 45, 21-31.
77.
Yaggi, H.K., Araujo, A.B., & McKinlay, J.B. (2006). Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care , 29, 657-661.
78.
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328, 1230-1235.
79.
Young, T., Peppard, P., & Gottlieb, D. (2002). Epidemiology of obstructive sleep apnea: A population health perspective. American Journal of Respiration andCritical Care Medicine, 165, 1217-1239.
